|
CCBL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00599981070582E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70940000043807E-07 |
| Normal-vs-Stage2 |
1.609450E-04 |
| Normal-vs-Stage3 |
5.41939999987306E-07 |
| Normal-vs-Stage4 |
5.226400E-04 |
| Stage1-vs-Stage2 |
6.766600E-01 |
| Stage1-vs-Stage3 |
6.053700E-02 |
| Stage1-vs-Stage4 |
2.998400E-01 |
| Stage2-vs-Stage3 |
2.604600E-01 |
| Stage2-vs-Stage4 |
4.509600E-01 |
| Stage3-vs-Stage4 |
8.504200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23520005124567E-10 |
| Normal-vs-AfricanAmerican |
4.41939999995533E-06 |
| Normal-vs-Asian |
6.403600E-03 |
| Caucasian-vs-AfricanAmerican |
3.222800E-01 |
| Caucasian-vs-Asian |
5.920200E-01 |
| AfricanAmerican-vs-Asian |
3.913000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.07269999946891E-07 |
| Normal-vs-Female |
3.777700E-04 |
| Male-vs-Female |
9.024300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.433300E-04 |
| Normal-vs-Extreme_Weight |
1.87289999953322E-07 |
| Normal-vs-Obese |
3.17330000054739E-07 |
| Normal-vs-Extreme_Obese |
6.122700E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.962300E-02 |
| Normal_Weight-vs-Obese |
5.030000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.707800E-01 |
| Extreme_Weight-vs-Obese |
9.861700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.685800E-01 |
| Obese-vs-Extreme_Obese |
9.160600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.240250E-04 |
| Normal-vs-Age(41-60Yrs) |
1.70099999641238E-08 |
| Normal-vs-Age(61-80Yrs) |
1.76790000416815E-08 |
| Normal-vs-Age(81-100Yrs) |
2.13219999999348E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.927600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.404600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.472600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.959800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.583200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.091200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.4433000067603E-09 |
| Normal-VS-Type2 PRCC |
6.63040000015158E-07 |
| Normal-VS-KIRP CIMP |
1.02150000003132E-06 |
| Normal-VS-Unclassified PRCC |
2.19519999955509E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.088600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.661800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.729000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.319200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.424000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.583000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.00480000051218E-07 |
| Normal-vs-N1 |
3.65239999999822E-06 |
| Normal-vs-N2 |
3.482900E-03 |
| N0-vs-N1 |
5.943400E-01 |
| N0-vs-N2 |
2.082800E-01 |
| N1-vs-N2 |
4.030400E-01 |
|
|
